PLx Pharma Inc.
NASDAQ:PLXP 3:59:52 PM EDT
Earnings Announcements
Plx Pharma Posts Q1 Adjusted Loss Per Share $0.66
Published: 05/13/2022 11:51 GMT
PLx Pharma Inc. (PLXP) - .
Reports First Quarter 2022 Results and Provides Business Update.
Q1 Adjusted Non-GAAP Loss per Share $0.66.
Q1 GAAP Loss per Share $0.39.
Q1 Sales $2.1 Million.
Cash & Cash Equivalent Balance of $52.5 Million As of March 31, 2022.
Reports First Quarter 2022 Results and Provides Business Update.
Q1 Adjusted Non-GAAP Loss per Share $0.66.
Q1 GAAP Loss per Share $0.39.
Q1 Sales $2.1 Million.
Cash & Cash Equivalent Balance of $52.5 Million As of March 31, 2022.
Revenue is expected to be $3.53 Million
Adjusted EPS is expected to be -$0.56
Next Quarter Revenue Guidance is expected to be $5.63 Million
Next Quarter EPS Guidance is expected to be -$0.44
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.56
Next Quarter Revenue Guidance is expected to be $5.63 Million
Next Quarter EPS Guidance is expected to be -$0.44
More details on our Analysts Page.